Qiagen N.V. financial data

Symbol
QGEN on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
Hulsterweg 82, Pl Venlo, Netherlands
State of incorporation
Netherlands
Fiscal year end
December 31
Former names
QIAGEN NV (to 2/14/2020)
Latest financial report
20-F - Q4 2024 - Mar 31, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 222M shares -2.59%
Common Stock, Value, Issued 2.6M USD -3.74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 664M USD -0.68%
Accounts Receivable, after Allowance for Credit Loss, Current 349M USD -8.54%
Inventory, Net 279M USD -29.9%
Assets, Current 1.96B USD -8.74%
Property, Plant and Equipment, Net 754M USD -1.49%
Operating Lease, Right-of-Use Asset 116M USD +10.5%
Intangible Assets, Net (Excluding Goodwill) 304M USD -42.3%
Goodwill 2.43B USD -2.03%
Other Assets, Noncurrent 244M USD +23.8%
Assets 5.69B USD -6.96%
Accounts Payable, Current 83.3M USD -1.05%
Employee-related Liabilities, Current 85.6M USD +5.16%
Accrued Liabilities, Current 51.7M USD -26.2%
Contract with Customer, Liability, Current 70.8M USD +6.62%
Liabilities, Current 544M USD -49.6%
Operating Lease, Liability, Noncurrent 96.7M USD +22.3%
Other Liabilities, Noncurrent 241M USD +16%
Accumulated Other Comprehensive Income (Loss), Net of Tax -475M USD -9.38%
Retained Earnings (Accumulated Deficit) 2.45B USD -0.35%
Stockholders' Equity Attributable to Parent 3.57B USD -6.31%
Liabilities and Equity 5.69B USD -6.96%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 410M shares 0%
Common Stock, Shares, Issued 224M shares -3%
Common Stock, Par or Stated Value Per Share 0.01 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 664M USD -0.68%
Deferred Tax Assets, Valuation Allowance 10.9M USD -17.6%
Deferred Tax Assets, Gross 144M USD +2.34%
Operating Lease, Liability 121M USD +19.4%
Lessee, Operating Lease, Liability, to be Paid 135M USD +23.2%
Property, Plant and Equipment, Gross 1.27B USD -0.93%
Operating Lease, Liability, Current 24.3M USD +9.28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 23.1M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 27.1M USD +7.69%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14.3M USD +67.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.2M USD +27.3%
Deferred Tax Assets, Operating Loss Carryforwards 33.9M USD -21.1%
Unrecognized Tax Benefits 109M USD +14%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.5M USD +26.1%
Additional Paid in Capital 1.67B USD -13%
Deferred Tax Assets, Net of Valuation Allowance 133M USD +4.4%